Abstract
pH-sensitive micelles are desirable for co-drug delivery in cancer chemotherapy. Herein, a novel, very pH-sensitive and biodegradable citric acid grafted poly maleate-block-poly lactic-co-glycolic acid was synthesized and assembled as micelles via ultrasonication. The engineered homogeneous nanomicelles were used for the first time for doxorubicin and conferone combination chemotherapy in the MDA-MB-231 breast cancer cell line. The physicochemical properties of the micelles were investigated via13CNMR, 1HNMR, FTIR, CHNS, DSC, SEM, and DLS-zeta analysis, and the in vitro degradation of the synthetic copolymer was investigated to confirm its biodegradability. The critical micelle concentration (CMC) value of the micelles was determined using pyrene as a probe and a spectrofluorometer. The drug release process was studied in acidic and neutral pH. The anti-tumoral properties of the dual drug-loaded micelles were investigated via MTT assay, cell cycle, and apoptosis experiments. The apoptosis was confirmed by Annexin-V, qRT-PCR and western blotting. The particle size (51.9 nm), zeta potential (−6.57 mV) and CMC (1.793 μg mL−1) of the co-drug loaded micelles were in the acceptable range for electrostatic stability. The uptake of the co-drug loaded micelles in the MDA-MB-231 cell line and spheroids was 97% and 36.1%, respectively. The cell cycle and apoptosis tests revealed that the cells treated with the co-drug-loaded micelles showed the highest amount of apoptosis (95.35%) in comparison to the single drug-loaded micelles and free drugs. Reverse transcription PCR (RT-PCR) showed that the expression levels of the proapoptotic genes were significantly up-regulated in the presence of the co-drug loaded micelles versus the single-drug loaded micelles and free drugs. Western blotting revealed that the co-drug-loaded micelles promoted apoptosis via the caspase-dependent pathway. Our findings confirmed that the pH-responsive biodegradable micelles containing doxorubicin and conferone are novel and effective for combination chemotherapy and offer a promising strategy for future in vivo studies.
Highlights
Multidrug resistance (MDR) and non-speci c toxicity result in chemotherapy failure.[1,2,3,4] combination therapy is used to overcome drug resistance in cancer patients.[2]
0.5 mg conferone, 0.1 mg Rhodamine B (RB) and 10 mg copolymer were dissolved in dimethyl sulfoxide (DMSO) and 0.5 mg doxorubicin was added to 1% PVA solution
The synthesis of the hydroxyl-terminated polymaleic anhydride was performed via thiol–ene addition between 2-mercaptoethanol (ME) and maleic anhydride (MA) in the presence of AIBN as a radical initiator
Summary
Overcoming its water insolubility via a new nano-formulation in order to decrease the effective dosage and side-effects of Dox. Flowcytometric analysis was used to study the cellular uptake of the blank and co-drug-loaded polymeric micelles containing Rhodamine B in the MDA-MB-231 cell line. To prepare the Rhodamine B-labeled blank micelles (RB-P), 10 mg copolymer and 0.1 mg Rhodamine B (RB) were dissolved in 1 mL DMSO This solution was added dropwise to 4 mL PVA 1% w/v solution, under probe sonication in the dark in an ice bath. The Rhodamine B-labeled co-drug-loaded micelles (RB-P2D) were prepared In this case, 0.5 mg conferone, 0.1 mg Rhodamine B (RB) and 10 mg copolymer were dissolved in DMSO and 0.5 mg doxorubicin was added to 1% PVA solution. A p value less than 0.05 was considered to be statistically signi cant
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.